Padwa et al.
was stirred at 25 °C for 10 h. The solution was concentrated
under reduced pressure and recrystallized from hexane/ether
to give 0.77 g (76%) of the titled compound as a pale yellow
solid: mp 100-101°C; IR (neat) 2134, 1720, 1669, 1480, 1318
and 1202 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.97 (t, 3H, J )
7.2 Hz), 1.28 (t, 3H, J ) 7.2 Hz), 1.70 (m, 1H), 1.80 (m, 1H),
2.05 (s, 3H), 2.25 (dt, 1H, J ) 13.0 and 4.4 Hz), 3.30 (m, 1H),
3.64 (dt, 1H, J ) 11.7 and 4.5 Hz), 4.22 (q, 2H, J ) 7.2 Hz),
and 5.59 (brs, 1H); 13C NMR (100 MHz, CDCl3) δ 10.0, 14.5,
18.9, 28.68, 28.71, 42.6, 57.6, 61.3, 76.6, 161.3, 173.0 and 191.5.
Anal. Calcd for C12H17N3O4: C, 53.92; H, 6.41; N, 15.72.
Found: C, 53.98; H, 6.45; N, 15.86.
mL) in THF (10 mL). After stirring for 8 h, the solvent was
removed under reduced pressure and the residue was dissolved
in ether, washed with sodium bicarbonate, basified to pH 10
with 10% NaOH, and washed with brine. The combined
organic phase was dried over MgSO4, filtered, and concen-
trated under reduced pressure. The crude material was
purified by flash column chromatography on silica gel (25%
EtOAc in hexane) to give 0.66 g (73%) of 29 as a white solid:
mp 139-142 °C; IR (neat) 2130, 1716, 1700, 1680, and 1470
1
cm-1; H NMR (400 MHz, CDCl3) δ 0.78 (t, 3H, J ) 7.2 Hz),
1.25 (t, 3H, J ) 7.2 Hz), 1.78 (m, 1H), 2.15 (m, 2H), 2.30 (dt,
1H, J ) 5.4 and 4.4 Hz), 3.70 (s, 1H), 4.00 (m, 1H), 4.20 (m,
3H), 5.60 (dd, 1H, J ) 13.8 and 1.2 Hz), 5.70 (dd, 1H, J ) 11.6
and 1.2 Hz), 6.90 (dd, 1H, J ) 13.8 and 11.6 Hz), 7.10 (m, 1H),
7.20 (m, 1H), 7.25 (m, 1H), and 7.60 (m, 1H); 13C NMR (100
MHz, CDCl3) δ 9.8, 14.5, 19.6, 28.3, 30.3, 30.9, 46.3, 59.8, 61.5,
75.8, 109.7, 119.7, 121.2, 122.1, 122.9, 125.6, 137.1, 139.1,
161.4, 170.9, 172.2, and 190.8. Anal. Calcd for C24H26N4O5: C,
63.99; H, 5.82; N, 12.44. Found: C, 64.05; H, 5.88; N, 12.49.
2-Diazo-3-[3-ethyl-2-oxo-1-(2-vinylbenzoyl)piperidin-3-
yl]-3-oxopropionic Acid Ethyl Ester (27). A 0.25 g (3.4
mmol) sample of 2-vinylbenzoic acid51 was dissolved in CH2-
Cl2 (10 mL), and 1.28 g (10.1 mmol) of oxalyl chloride was
added dropwise. The mixture was stirred for 1 h, concentrated
under reduced pressure, and dissolved in THF (10 mL). This
solution was added dropwise over 1 h to a vigorously stirred
mixture containing 0.45 g (3.4 mmol) of 2-diazo-3-(3-ethyl-2-
oxopiperidin-3-yl)-3-oxopropionic acid ethyl ester and 3 g of 4
Å molecular sieves in THF (10 mL). After stirring for 8 h, the
mixture was filtered through a pad of Celite and concentrated
under reduced pressure. The crude material was purified by
flash column chromatography on silica gel (10% EtOAc in
hexane) to give 0.94 g (70%) of 27 as a clear oil: IR (neat)
3a-Ethyl-2,12c-epoxy-12c-methyl-3,7-dioxo-1,2,3a,4,5,6,-
7,12,12b,12c-decahydro-3H-6a,12-diazaindeno[2,1-a]-
phenalene-2-carboxylic Acid Ethyl Ester (31). A 0.07 g
(0.15 mmol) sample of the above diazo amide 29 was dissolved
in benzene (5 mL). Rhodium(II) acetate (6 mg) was added and
the solution was stirred for 3 days at room temperature. The
solution was filtered through a pad of Celite with ether (5 mL).
The mixture was concentrated under reduced pressure. The
crude material was purified by flash column chromatography
on silica gel to give 0.06 g of 31 as a white solid in 92% yield:
1
2136, 1711, 1680, 1327, 1260, 1178, and 1142 cm-1; H NMR
(400 MHz, CDCl3) δ 0.81 (t, 3H, J ) 7.2 Hz), 1.27 (t, 3H, J )
7.2 Hz), 1.75 (m, 1H), 2.05 (m, 4H), 2.29 (m, 1H), 3.90 (m, 1H),
4.20 (m, 3H), 5.26 (dd, 1H, J ) 11.2 and 0.8 Hz), 5.70 (dd, 1H,
J ) 17.4 and 0.8 Hz), 7.76 (dd, 1H, J ) 17.4 and 11.2 Hz),
IR (neat) 1767, 1736, 1654, 1490, 1475, and 1378 cm-1 1H
;
NMR (400 MHz, CDCl3) δ 1.09 (t, 3H, J ) 7.2 Hz), 1.14 (t, 3H,
J ) 7.2 Hz), 1.70 (m, 3H), 1.90 (m, 3H), 2.40 (m, 1H), 2.75 (m,
1H), 3.20 (m, 1H), 3.65 (s, 1H), 3.90 (m, 1H), 4.15 (q, 2H, J )
7.2 Hz), 4.50 (m, 1H), 7.20 (m, 3H), and 8.20 (m, 1H); 13C NMR
(100 MHz, CDCl3) δ 9.2, 14.3, 18.7, 24.1, 24.5, 30.9, 34.2, 35.8,
39.7, 50.9, 62.5, 85.1, 99.0, 103.5, 109.3, 121.6, 122.4, 123.1,
125.3, 137.8, 143.0, 164.9, 165.2, and 208.0.
7.11 (m, 1H), 7.20 (m, 1H), 7.32 (m, 1H), and 7.55 (m, 1H); 13
C
NMR (100 MHz, CDCl3) δ 9.8, 14.5, 19.4, 28.1, 30.7, 45.1, 59.7,
61.6, 76.0, 116.4, 125.2, 126.0, 127.2, 129.3, 134.4, 134.8, 161.6,
172.5, 174.1 and 190.3.
9-Aza-13-(ethoxycarbonyl)-16-oxa-8,14-dioxopentacy-
clo[13.2.1.02,7.09.17.013,14]-octadeca-2(3),4,5-triene-15-eth-
yl Ester (28). To an argon-filled round-bottom flask containing
0.08 g (0.2 mmol) of diazo amide 27 in benzene (10 mL) was
added 4 mg (5 mol %) of dirhodium(II) tetraacetate. After
stirring for 18 h, the mixture was filtered through a pad of
Celite and concentrated under reduced pressure. The crude
residue was purified by flash column chromatography on silica
gel (10% EtOAc in hexane) to give 0.07 g (95%) of 28 as a white
solid: mp 221-223 °C; IR (neat) 1767, 1742, 1700, and 1373
3a-Ethyl-2-hydroxy-12-methyl-3,7-dioxo-1,2,3a,4,5,6,7,-
12-octahydro-3H-6a,12-diaza-indeno[2,1-a]phenalene-2-
carboxylic Acid Ethyl Ester (32). A 0.06 g (0.14 mmol)
sample of cycloadduct 31 was heated at reflux in ether for 5
min. The mixture was allowed to cool and was stored at 0 °C
for 10 h. The solution was concentrated under reduced pres-
sure, and the crude material was purified by flash column
chromatography on silica gel (4% methanol in CH2Cl2) to give
pyridone 32 in 90% yield: mp 252-255 °C; IR (neat) 1767,
1721, 1629, and 1209 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.87
(t, 3H, J ) 7.2 Hz), 1.40 (t, 3H, J ) 7.2 Hz), 2.10 (m, 6H), 3.77
(d, 1H, J ) 16.0 Hz), 3.85 (d, 1H, J ) 16.0 Hz), 3.98 (m, 1H),
4.05 (s, 3H), 4.10-4.20 (m, 1H), 4.37 (dq, 1H, J ) 10.8 and
7.2 Hz), 4.47 (dq, 1H, J ) 10.8 and 7.2 Hz), 7.25 (m, 3H), and
8.40 (d, 1H, J ) 8.0 Hz); 13C NMR (100 MHz, CDCl3) δ 8.9,
14.3, 19.2, 28.2, 31.2, 32.1, 33.4, 42.0, 52.1, 63.4, 75.6, 100.2,
107.4, 108.7, 121.8, 122.1, 124.3, 124.6, 140.3, 140.9, 143.5,
160.2, 171.5, and 205.4. Anal. Calcd for C24H26N2O5: C, 68.23;
H, 6.20; N, 6.63. Found: C, 68.41; H, 6.50; N, 6.34.
(2-Bromo-1-methyl-1H-indol-3-yl)acetic Acid Ethyl Es-
ter. A sample of (2-bromo-1H-indol-3-yl)-acetic acid ethyl
ester53 (1.7 g, 6 mmol) was taken up in acetonitrile (15 mL)
and then 60% sodium hydride (0.24 g, 6 mmol) was added.
The reaction mixture was stirred for 5 min and methyl iodide
(1 g, 7.2 mmol) was added in one portion and the solution was
stirred for 2 h. The mixture was diluted with water and the
aqueous layer was taken up in EtOAc. The organic phase was
collected and washed with sodium bicarbonate and brine. The
combined organic phase was dried over MgSO4, filtered, and
concentrated under reduced pressure. The crude material was
purified by flash column chromatography on silica gel (10%
1
cm-1; H NMR (400 MHz, CDCl3) δ 1.16 (t, 3H, J ) 7.2 Hz),
1.31 (t, 3H, J ) 7.2 Hz), 1.72 (m, 3H), 1.95 (m, 3H), 2.53 (dd,
1H, J ) 13.6 and 4.8 Hz), 2.81 (dd, 1H, J ) 13.6 and 9.2 Hz),
3.27 (dt, 1H, J ) 13.2 and 4.0 Hz), 3.82 (m, 1H), 4.29 (m, 2H),
4.58 (m, 1H), 7.14 (m, 1H), 7.37 (m, 1H), 7.54 (m, 1H), and
8.18 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 9.1, 14.3, 18.5,
24.3, 37.0, 38.1, 40.5, 50.2, 62.4, 85.6, 96.6, 125.6, 127.1, 127.4,
128.9, 133.4, 139.6, 164.7, 165.2, and 207.6. Anal. Calcd for
C21H23NO5: C, 68.28; H, 6.28; N, 3.79. Found: C, 68.07; H,
6.34; N, 3.64.
2-Diazo-3-[3-ethyl-1-(1-methyl-2-vinyl-1H-indole-3-car-
bonyl)-2-oxopiperidin-3-yl]-3-oxopropionic Acid Ethyl
Ester (29). A 0.4 g sample (2 mmol) of 1-methyl-2-vinylindole-
3-carboxylic acid52 was dissolved in CH2Cl2 (20 mL). To this
solution was added oxalyl chloride (0.7 mL, 7 mmol) dropwise,
and the solution was stirred for 30 min, concentrated under
reduced pressure, and dissolved in THF (10 mL). This solution
was added dropwise over 1 h to a vigorously stirred mixture
of 0.56 g (3.4 mmol) of 2-diazo-3-(3-ethyl-2-oxopiperidin-3-yl)-
3-oxopropionic acid ethyl ester and triethylamine (0.61 g, 0.84
(49) Choi, D. S.; Huang, S.; Huang, M.; Barnard, T. S.; Adams, R.
D.; Seminario, J. M.; Tour, J. M. J. Org. Chem. 1998, 63, 2646.
(50) Ku¨ndig, E. P.; Perret, C. Helv. Chim. Acta 1981, 8, 2606.
(51) Chamoin, S.; Houldsworth, S.; Snieckus, V. Tetrahedron Lett.,
1998, 39, 4175.
(52) Laronze, M.; Laronze, J. Y.; Nemes, C.; Sapi, J. Eur. J. Org.
Chem. 1999, 9, 2285.
(53) Jirousek, M. R.; Paal, M.; Ruhter, G.; Schotten, T.; Stenzel, W.;
Takeuchi, K. Eur. Pat. Appl. 1999, EP 924209-A1; 19990623; US 97-
68195; 19971219. CAN 131:58827; AN 1999:401581.
2214 J. Org. Chem., Vol. 70, No. 6, 2005